Taiwan Headline

• Botanicure presented clinical findings regarding its botanical drug development for early dementia at the BIO International Convention. • The presentation focused on the efficacy and safety of the botanical-based treatment in addressing cognitive decline. • This development is significant as it explores alternative, plant-derived therapeutic pathways for treating dementia, a growing global health challenge.

• Botanicure presented clinical findings regarding the development of a botanical drug for early dementia at the BIO International Convention. • The presentation highlighted the efficacy and safety data of their botanical drug candidate during the global biotechnology gathering. • This development is significant as it explores plant-based therapeutic alternatives for treating cognitive decline and early-stage dementia.

• Botanicure presented clinical findings regarding the development of a botanical drug for early dementia at the BIO International Convention. • The presentation highlighted the efficacy and progress of their botanical-based therapeutic approach to treating cognitive decline. • This development is significant as it explores alternative, plant-derived pharmacological pathways to address the growing global challenge of dementia.

• Botanicure presented clinical findings regarding the development of a botanical drug for early dementia at the BIO International Convention. • The presentation highlighted the efficacy and safety data of their botanical drug candidate during the global biotechnology gathering. • This development is significant as it explores plant-based therapeutic alternatives for treating cognitive decline and early-stage dementia.

• Botanicure presented clinical findings for a botanical drug designed to treat early dementia during the BIO International Convention. • The presentation highlighted the development process and efficacy of the botanical-based treatment for cognitive impairment. • This development is significant as it explores alternative, plant-derived pharmaceutical pathways to address the growing global burden of dementia.

• Botanicure presented clinical findings for a botanical drug targeting early dementia at the BIO International Convention. • The presentation focused on the development and efficacy of botanical-based treatments to address cognitive decline. • This research is significant as it explores alternative pharmaceutical pathways to treat dementia, a growing global health challenge.

• Botanicure presented clinical findings regarding the development of a botanical drug designed to treat early-stage dementia. • The findings were unveiled during the BIO International Convention, highlighting the company's progress in botanical pharmaceutical research. • This development is significant as it explores alternative, plant-based therapeutic pathways to address the growing global challenge of cognitive decline.